Atlas Trials

Evaluation of PSMA-PET and mpMRI in High-risk Prostate Cancer - Using Histopathologic Validation

Clinical trial NCT06565247 · RECRUITING

Trial details

NCT number
NCT06565247
Sponsor
Region Västerbotten
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2024-10-14
Primary completion
2026-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.